• Explore /
  • Poster
  • / Apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer: A randomized trial (PERSIAN).

Apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer: A randomized trial (PERSIAN).

Abstract Poster

Authors

null

Giulio Francolini

Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy

Giulio Francolini , Angelo Porreca , Gaetano Facchini , Daniele Santini , Alessio Bruni , Nicola Simoni , Marco Trovò , Mattia Falchetto Osti , Giuseppe Fornarini , Michele Sisani , Vanessa Di Cataldo , Beatrice Detti , Pietro Garlatti , Niccolò Bertini , Luca Burchini , Giulio Frosini , Ilaria Bonaparte , Sergio Serni , Andrea Minervini , Lorenzo Livi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05717660

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr TPS235)

DOI

10.1200/JCO.2024.42.4_suppl.TPS235

Abstract #

TPS235

Poster Bd #

P18

Abstract Disclosures

Similar Posters

First Author: Guillaume Grisay

First Author: Alberto Carretero-González

First Author: Praful Ravi

First Author: Bridget F. Koontz